查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684772

心肺機市場機會、成長動力、產業趨勢分析和 2025 - 2034 年預測

Heart-lung Machine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球心肺機市場價值為 3.698 億美元，並將大幅擴張，預計 2025 年至 2034 年的年複合成長率(CAGR) 為 4.6%。隨著心血管疾病的增加和器官移植手術的增加，心肺機的需求激增。這些機器在複雜的外科手術過程中提供生命維持至關重要，例如心臟手術和器官移植，穩定的血液循環和氧合至關重要。它們在提高患者存活率和改善治療效果方面發揮的作用正在推動醫院、診所和其他醫療機構的廣泛採用。心肺機的技術創新，包括更有效率、更用戶友善的系統，也在推動市場成長。隨著全球醫療保健系統的現代化和擴大獲得先進治療的機會，對可靠和高性能心肺機的需求變得越來越重要。

心肺機市場 - IMG1

市場主要分為兩大類：單滾輪泵浦系統和雙滾輪泵浦系統。單滾輪泵浦市場預計將佔據主導地位，年複合成長率為 4.3%，到 2034 年將達到 3.37 億美元。這些幫浦以其在手術期間提供穩定血流的可靠性而聞名，這對於維持穩定的體外膜氧合 (ECMO) 至關重要。它們設計簡單且經濟高效，成為醫院和醫療機構的熱門選擇，尤其是在經常需要精打細算的解決方案的新興市場。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 3.698 億美元
預測值 5.759 億美元
複合年成長率 4.6％

從應用方面來看，心肺機主要用於醫院和診所、門診手術中心和其他醫療機構。醫院和診所部門預計將穩定成長，到 2034 年將達到 2.414 億美元。這些機器在重症監護中發揮關鍵作用，特別是在移植後過程中，它們有助於穩定患者病情並降低器官排斥的風險。它們在支持免疫抑制療法方面的有效性進一步鞏固了它們在世界各地醫院和診所中的重要地位。

光是在美國，2024 年心肺機市場價值就達到 1.396 億美元，預計到 2034 年複合年成長率將達到 3.9%。這一成長是由大量心臟手術推動的，例如冠狀動脈繞道術 (CABG) 和瓣膜置換術，這些手術需要可靠的心肺機支持。強大的醫療保健基礎設施、優惠的報銷政策以及持續的研發投資等因素繼續使美國在全球市場佔據領先地位。隨著心血管疾病發病率的不斷上升，美國對心肺機的需求預計將上升，確保這一關鍵市場繼續成長。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 心血管疾病發生率不斷上升
      • 器官移植手術數量不斷增加
      • 心肺機的技術進步
    • 產業陷阱與挑戰
      • 先進心肺機價格昂貴
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 報銷場景
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未來市場趨勢

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2034 年

  • 主要趨勢
  • 單滾輪泵
  • 雙滾輪泵

第 6 章：市場估計與預測：按應用，2021 - 2034 年

  • 主要趨勢
  • 心臟手術
  • 肺部手術
  • 急性呼吸衰竭治療
  • 其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2034 年

  • 主要趨勢
  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • BRAILE
  • Edwards
  • ELITE LIFE CARE
  • EUROSETS
  • FRESENIUS MEDICAL CARE
  • GETINGE
  • HEART CARE INDIA CO
  • hemovent
  • Jarvik HEART
  • LivaNova
  • Medtronic
  • NIPRO
  • Palex
  • Philips
  • TERUMO
簡介目錄
Product Code: 6060

The Global Heart-Lung Machine Market, valued at USD 369.8 million in 2024, is set to expand significantly, with an expected compound annual growth rate (CAGR) of 4.6% from 2025 to 2034. As cardiovascular diseases rise and organ transplant surgeries increase, the demand for heart-lung machines has surged. These machines are crucial in providing life support during complex surgical procedures, such as cardiac surgeries and organ transplants, where stable blood circulation and oxygenation are vital. Their role in enhancing patient survival rates and improving outcomes is driving widespread adoption across hospitals, clinics, and other healthcare facilities. Technological innovations in heart-lung machines, including more efficient and user-friendly systems, are also propelling market growth. As healthcare systems globally modernize and expand access to advanced treatments, the need for reliable and high-performing heart-lung machines becomes increasingly important.

Heart-lung Machine Market - IMG1

The market is divided into two main categories: single-roller pump systems and double-roller pump systems. The single-roller pump segment is expected to dominate, growing at a CAGR of 4.3% and reaching USD 337 million by 2034. These pumps are known for their reliability in providing consistent blood flow during surgeries, which is essential for maintaining stable extracorporeal membrane oxygenation (ECMO). Their simple design and cost-effectiveness make them a popular choice in hospitals and healthcare facilities, especially in emerging markets where budget-conscious solutions are often required.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$369.8 Million
Forecast Value$575.9 Million
CAGR4.6%

In terms of application, heart-lung machines are primarily used in hospitals and clinics, ambulatory surgical centers, and other medical institutions. The hospitals and clinics segment is anticipated to grow steadily, reaching USD 241.4 million by 2034. These machines play a key role in critical care, especially during post-transplantation procedures, where they help stabilize patients and reduce the risk of organ rejection. Their effectiveness in supporting immunosuppressive therapies further reinforces their essential presence in hospitals and clinics worldwide.

In the U.S. alone, the heart-lung machine market was valued at USD 139.6 million in 2024 and is projected to grow at a CAGR of 3.9% through 2034. This growth is driven by the high volume of cardiac surgeries, such as coronary artery bypass grafting (CABG) and valve replacements, which require reliable heart-lung machine support. Factors like a strong healthcare infrastructure, favorable reimbursement policies, and ongoing investments in research and development continue to position the U.S. as a leader in the global market. With the increasing incidence of cardiovascular diseases, the demand for heart-lung machines in the U.S. is expected to rise, ensuring the continued growth of this critical market.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cardiovascular disease
      • 3.2.1.2 Growing number of organ transplant surgeries
      • 3.2.1.3 Technological advancements in heart-lung machines
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced heart-lung machines
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Single roller pump
  • 5.3 Double roller pump

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiac surgeries
  • 6.3 Lung surgeries
  • 6.4 Acute respiratory failure treatment
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals and clinics
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 BRAILE
  • 9.2 Edwards
  • 9.3 ELITE LIFE CARE
  • 9.4 EUROSETS
  • 9.5 FRESENIUS MEDICAL CARE
  • 9.6 GETINGE
  • 9.7 HEART CARE INDIA CO
  • 9.8 hemovent
  • 9.9 Jarvik HEART
  • 9.10 LivaNova
  • 9.11 Medtronic
  • 9.12 NIPRO
  • 9.13 Palex
  • 9.14 Philips
  • 9.15 TERUMO